BCL3 anticorps (C-Term)
Aperçu rapide pour BCL3 anticorps (C-Term) (ABIN3073233)
Antigène
Voir toutes BCL3 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- Bcl 3 (B Cell CLL/lymphoma 3, B Cell Leukemia 3, B Cell Leukemia/lymphoma 3, B Cell Lymphoma 3 Encoded Protein, BCL3, BCL4, Chronic Lymphatic Leukemia Protein, D19S37, Protein Bcl 3)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to the C-terminal region of human BCL3
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.4, 1 % BSA and 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- BCL3 (B-Cell CLL/lymphoma 3 (BCL3))
-
Autre désignation
- Bcl 3
-
Pathways
- Signalisation NF-kappaB, Maintenance of Protein Location, Protein targeting to Nucleus
Antigène
-